Long‐term experience with a totally implanted catheter system in cancer patients

Cesar O. Freytes, Patricia Reid, Kirby L. Smith

Research output: Contribution to journalArticlepeer-review

35 Scopus citations


Long‐term experience with totally implanted catheter systems (TICS) is limited. We retrospectively evaluated the performance and long‐term complications of TICS for intravenous infusion in cancer patients; 134 systems were implanted in 128 patients. The median duration of implantation was 144 weeks with 49 systems implanted for more than one year. Complications related to surgical factors included malposition of reservoir (2%), skin perforation or wound dehiscence (1.5%) and pneumothorax (< 1%). Complications not related to surgical factors included: drug extravasation (1.5%), mechanical malfunction (1.5%), vein thrombosis (< 1%), clotting of the reservoir or catheter (2%), skin infection (1.5%), and sepsis (< 1%). The total complication rate was 13%. Most complications resolved spontaneously or with medical treatment and only 6 patients (4.6%) required re‐implantation of a second system. We conclude that with long‐term usage of TICS, the complication rate remains low, making it a safe and viable alternative for patients requiring long‐term intravenous therapy.

Original languageEnglish (US)
Pages (from-to)99-102
Number of pages4
JournalJournal of Surgical Oncology
Issue number2
StatePublished - Oct 1990


  • catheters
  • chemotherapy
  • vascular access problems

ASJC Scopus subject areas

  • Surgery
  • Oncology


Dive into the research topics of 'Long‐term experience with a totally implanted catheter system in cancer patients'. Together they form a unique fingerprint.

Cite this